Axol Bioscience logo

Axol Bioscience

ID: 6029413

Provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research

2

Funding Rounds

$7.0m

Money raised

Overview

Provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Axol Bioscience has raised a total of $7m in funding over 2 rounds.

Key Insights:

  • Axol Bioscience Seed Round, January 2026: $2.8m
  • Axol Bioscience March 2022 Funding Round: $4.2m

Industries

Axol Bioscience is active in the following industries: